Healthcare >> Analyst Interviews >> March 9, 2009

Canadian Healthcare Companies – Claude Camire – Paradigm Capital Inc.

Claude Camire is senior biotech analyst at Paradigm Capital Inc. He has been an analyst for nine years for various firms including Dundee Securities and Groome Capital. He has also worked for more than 15 years for various pharmaceutical companies such as Abbott Laboratories, Sanofi-Aventis, Biochem Pharma (now part of Shire Pharmaceutical Inc.) and ProMetic Life Sciences in various functions. He graduated from the University of Sherbrooke and obtained his B Comm with a major in Finance. Profile
TWST: Where do you focus your attention in the Canadian healthcare space?

Mr. Camire: Right now, we are focusing on healthcare companies that generate

revenues or are close to; we are trying